CBIO
Crescent Biopharma, Inc.
14.30$
+0.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -76,150.0% | – | – | – | – | – | – | -57.4% | -246.6% | -860.2% | – | -171.2% | |
| – | 233.0% | – | – | – | – | – | – | 0.1% | 0.5% | 6.2% | – | 0.5% | |
| – | 9,443.7% | – | – | – | – | – | – | 6.5% | 43.8% | 395.9% | – | 34.9% | |
| – | 2,998.7% | – | – | – | – | – | – | 16.2% | -177.4% | 969.4% | – | -2.8% | |
| – | 8.0% | – | – | – | – | – | – | 1.9% | 665.7% | 784.1% | – | 190.7% | |
| – | -8.0% | – | – | – | – | – | – | -1.9% | -665.7% | -784.1% | – | -186.5% | |
| – | – | – | – | – | – | – | – | – | 1.6% | – | – | – | |
| – | 10.0% | – | – | – | – | – | – | -4.1% | 1,649.4% | -668.4% | – | 402.4% | |
| – | -76,148.0% | – | – | – | – | – | – | -63.4% | 737.1% | -2,312.7% | – | 44.6% | |
| – | -76,158.0% | – | – | – | – | – | – | -59.3% | -912.3% | -1,644.3% | – | -361.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.